Long Tail EHR Integration Challenge

The bottleneck is not note generation, it is getting that note to land in the right place inside dozens of different clinical systems without breaking the workflow. Freed can win early with copy paste and light browser push because solo doctors mostly need a usable note fast, but moving upmarket means handling specialty templates, diagnosis fields, order entry, and billing steps that change across fragmented outpatient EHRs.1 2 3 4

• Small practice EHRs are highly fragmented. Beyond Epic, outpatient care runs on Athenahealth plus hundreds of niche systems for areas like behavioral health, dental, and physical therapy. Each has different fields, screens, and workflows, so one generic connector rarely gets deep enough to automate the full visit.4
• That is why Freed started with the lightest workflow. The product records the visit, drafts a structured note, and sells self serve for $99 per month to individual clinicians. This keeps distribution cheap, but it also means the product can deliver value before deep integration is complete.2 3
• The contrast with Abridge shows what deep integration buys. Abridge became Epic’s first Pal in August 2023, built note writing and additional workflow steps inside Epic, and then scaled to 60,000 plus clinicians across 100 plus health systems with estimated ARR of $100M by May 2025. Freed reached $19M ARR by March 2025 with 17,000 clinicians through a lighter weight model.2 5 6 7

The next phase of competition is a split market. Enterprise winners will be the companies that go deepest inside a few major EHRs, while bottom up players like Freed can keep growing by owning small practice workflows and selectively adding integrations where demand is densest. Over time, the strongest products will look less like stand alone scribes and more like EHR specific automation layers.1 2 4 5 6